BMY FY 2019 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena

BMYBristol-Myers Squibb Company

$121B

FY 2019 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$26.1B+15.9% YoY

Gross Profit

$17.3B66.0% margin

Operating Income

$6.4B24.6% margin

Net Income

$3.4B13.2% margin

EPS (Diluted)

$2.01

Cash Flow

Operating Cash Flow

$8.2B

Free Cash Flow

$7.4B

Stock-Based Comp.

$441M

Balance Sheet

Total Assets

$129.9B

Total Liabilities

$78.2B

Stockholders' Equity

$51.6B

Cash & Equivalents

$12.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$26.1B	$22.6B	+15.9%
Gross Profit	$17.3B	$16.1B	+7.3%
Operating Income	$6.4B	$6.4B	+0.7%
Net Income	$3.4B	$4.9B	-30.1%